Cite
HARVARD Citation
Albino, V. et al. (n.d.). Neoadjuvant folfiri + bevacizumab in patients with resectable liver metastases from colo-rectal cancer: Results from a phase 2 trial and comparative analysis of early PET/CT scan vs recist criteria in predicting outcome. European journal of surgical oncology. 42 (10), pp. S210-. [Online].